Xenon Pharmaceuticals
XENE
XENE
205 hedge funds and large institutions have $2.6B invested in Xenon Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 76 increasing their positions, 56 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% more capital invested
Capital invested by funds: $2.58B → $2.6B (+$26M)
0% less funds holding
Funds holding: 206 → 205 (-1)
29% less funds holding in top 10
Funds holding in top 10: 14 → 10 (-4)
Holders
205
Holding in Top 10
10
Calls
$11.4M
Puts
$9.75M
Top Buyers
| 1 | +$104M | |
| 2 | +$56.6M | |
| 3 | +$33.6M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$28.2M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
+$28M |
Top Sellers
| 1 | -$50.5M | |
| 2 | -$49.1M | |
| 3 | -$34.1M | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$22.5M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$21.8M |
